BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35330518)

  • 21. Significance of TNM staging, Demographic and Histologic Features in Predicting the Prognosis of Renal Cell Carcinoma.
    Kucuk U; Pala EE; Sezer O; Cakir E; Bayol U; Divrik RT
    Acta Chir Belg; 2015; 115(3):202-7. PubMed ID: 26158251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
    Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
    Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
    Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy.
    Zhou L; Chang Y; Xu L; Liu Z; Fu Q; Yang Y; Lin Z; Xu J
    J Urol; 2016 Aug; 196(2):335-42. PubMed ID: 26970566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma.
    Berger DA; Megwalu II; Vlahiotis A; Radwan MH; Serrano MF; Humphrey PA; Piccirillo JF; Kibel AS
    Urology; 2008 Aug; 72(2):359-63. PubMed ID: 18468663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma.
    Choi JY; Ko YH; Song PH
    Investig Clin Urol; 2016 Sep; 57(5):324-9. PubMed ID: 27617313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and validation of an eight-gene expression signature for predicting high Fuhrman grade renal cell carcinoma.
    Wan F; Zhu Y; Han C; Xu Q; Wu J; Dai B; Zhang H; Shi G; Gu W; Ye D
    Int J Cancer; 2017 Mar; 140(5):1199-1208. PubMed ID: 27874173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
    Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
    Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
    May M; Ficarra V; Shariat SF; Zigeuner R; Chromecki T; Cindolo L; Burger M; Gunia S; Feciche B; Wenzl V; Aziz A; Chun F; Becker A; Pahernik S; Simeone C; Longo N; Zucchi A; Antonelli A; Mirone V; Stief C; Novara G; Brookman-May S; ;
    J Urol; 2013 Aug; 190(2):458-63. PubMed ID: 23434943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
    Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases.
    Zhang C; Li X; Hao H; Yu W; He Z; Zhou L
    BJU Int; 2012 Dec; 110(11 Pt B):E481-5. PubMed ID: 22540142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with pathological tumor stage and T3a upstage in clinical T1-2 renal cell carcinoma.
    Kalfazade N; Özlü DN; Şam E; Akkaş F; Gürbüz N
    Prog Urol; 2023 Mar; 33(3):135-144. PubMed ID: 36604246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of increased preoperative serum high sensitive C-reactive protein and procalcitonin levels on grade and stage of clear cell renal cell carcinoma.
    Hamidi N; Gökçe MI; Süer E; Baltaci S
    Clin Nephrol; 2015 Apr; 83(4):225-30. PubMed ID: 25707457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Best Practice No 180. Nephrectomy for renal tumour; dissection guide and dataset.
    Fleming S; Griffiths DF
    J Clin Pathol; 2005 Jan; 58(1):7-14. PubMed ID: 15623474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
    Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK
    Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens.
    Minardi D; Lucarini G; Mazzucchelli R; Milanese G; Natali D; Galosi AB; Montironi R; Biagini G; Muzzonigro G
    J Urol; 2005 Oct; 174(4 Pt 1):1208-12. PubMed ID: 16145371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in renal cell carcinoma: analysis of 227 patients treated at the Brazilian National Cancer Institute.
    Ornellas AA; Andrade DM; Ornellas P; Wisnescky A; Schwindt AB
    Int Braz J Urol; 2012; 38(2):185-94. PubMed ID: 22555027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
    Lughezzani G; Capitanio U; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Perrotte P; Montorsi F; Karakiewicz PI
    Cancer; 2009 Dec; 115(24):5680-7. PubMed ID: 19824083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.